Clinical trials: Hyperferritinemia, active
Lymphohistiocytosis, Hemophagocytic, Secondary Hemophagocytic Lymphohistiocytosis
Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study
Background: Hemophagocytic lymphohistiocytosis (HLH) is a disease caused by disrupted immune function. People with HLH are prone to fevers and illnesses, which can be fatal.
- Conditions
- Lymphohistiocytosis, Hemophagocytic, Secondary Hemophagocytic Lymphohistiocytosis, Macrophage Activation Syndrome, Hyperinflammatory Syndromes
- Trial name
- NCT06339177
- Where
- 2 sites in United States
- Volunteers
- 300 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
Critical Illness, Sepsis
Hyperinflammation and Hyperferritinemia in Critically Ill Patients
Analysing trajectory of critically ill patients with signs of hyperinflammation
- Conditions
- Critical Illness, Sepsis, Hyperferritinemia, Hyperinflammatory Syndrome
- Trial name
- HYFER (NCT06820905)
- Where
- Czechia
- Volunteers
- 1,962 people
- Sponsor
- Charles University, Czech Republic